This page contains our statements regarding the actions or inactions of various national, regional, and world public health agencies, including the FDA, NIH, WHO, etc.
May 12, 2021 | Public Statement
FLCCC Alliance Statement on the Irregular Actions of Public Health Agencies and the Widespread Disinformation Campaign Against Ivermectin
Awareness of ivermectin’s efficacy and its adoption by physicians worldwide to successfully treat COVID-19 have grown exponentially over the past several months. Oddly, however, even as the clinical trials data and successful ivermectin treatment experiences continue to mount…Read Full Statement
April 7, 2021 | Article
Expanding Our Strategy to End The Pandemic
Dr. Pierre Kory and Dr. Colleen Aldous write that the World Health Organization and National Institutes of Health now have all the data they need to recommend ivermectin to prevent and treat COVID-19—and put an end to the pandemic.
March 31, 2021 | Public Statement
FLCCC Alliance Statement on Weak Guidance on Ivermectin from the World Health Organization
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19.
March 7, 2021 | Public Statement
FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.
Feb 28, 2021 | Public Statement
FLCCC Alliance Response to the N.I.H. Guideline Committee Recommendation on Ivermectin use in COVID-19 dated February 11, 2021
Jan 17, 2021 | Public Statement
FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th, 2021
The FLCCC considers the Panel’s unwillingness to provide more specific guidance in support of the use of ivermectin in COVID-19 to be severely out of alignment with the known clinical, epidemiological, and observational data. Our detailed response to the Panel’s criticism of the existing evidence base […]